Matthew Biegler

Stock Analyst at Oppenheimer

(0)
# 4975
Out of 5,311 analysts
92
Total ratings
16.92%
Success rate
-36.29%
Average return
26 Stocks
Name Action Price Target Current % Upside Ratings Updated
VOR Vor Biopharma
Reiterates: Outperform
8 8
0.63 1169.84% 7 Mar 21, 2025
OLMA Olema Pharmaceutical...
Reiterates: Outperform
30 25
3.4 635.29% 5 Mar 19, 2025
ARVN Arvinas
Maintains: Outperform
40 45
6.62 579.76% 4 Feb 12, 2025
GILD Gilead Sciences
Reiterates: Outperform
105 115
101.29 13.54% 1 Dec 10, 2024
IDYA IDEAYA Biosciences
Reiterates: Outperform
53 53
15.79 235.66% 5 Oct 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
25 33
7.53 338.25% 6 Sep 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
20 20
1.12 1685.71% 7 Sep 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 6 Sep 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
17 15
4.29 249.65% 4 Aug 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Outperform
13 11
1.38 697.1% 1 Aug 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
114 125
80.33 55.61% 5 Jul 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Peer Perform
n/a
n/a n/a 4 Jul 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
16 14
2.62 434.35% 5 May 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Perform
n/a
n/a n/a 1 Apr 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
33 44
n/a n/a 1 Mar 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Perform
n/a
n/a n/a 5 Feb 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Perform
n/a
n/a n/a 2 Feb 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
8 3
n/a n/a 4 Aug 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
1500 450
n/a n/a 5 Aug 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
30
n/a n/a 1 Jun 2, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
25
1.5 1566.67% 1 Jun 2, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 3 Dec 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 2 Dec 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
520 360
5.25 6757.14% 1 Nov 30, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 3 Feb 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
115 105
n/a n/a 3 Jan 21, 2022